Sanai Health Industry Group Company Limited provided earnings guidance for the year ended 31 December 2022. For the year, the Group is expected to record (i) a revenue of approximately RMB 175.92 million for the year ended 31 December 2022 (the "Period''), representing an increase of approximately 160.2% as compared with the year ended 31 December 2021; and (ii) a profit attributable to owners of the Company of approximately RMB 29.22 million for the Period, representing an increase of approximately 223.6% as compared with the year ended 31 December 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.027 HKD | +8.00% | -10.00% | -57.81% |
1st Jan change | Capi. | |
---|---|---|
-57.81% | 12.21M | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- 1889 Stock
- News Sanai Health Industry Group Company Limited
- Sanai Health Industry Group Company Limited Provides Earnings Guidance for the Year Ended 31 December 2022